Search research articles
Contact Us
Filters
Showing results (731-740 of 743) with videos related to
Page
of 75
Sort By:
Journal of Medicinal Chemistry
|
February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors
Noel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
American Journal of Human Genetics
|
November 11, 2008
Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis
Tie-Lin Yang, Xiang-Ding Chen, Yan Guo, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
The Lancet. Infectious Diseases
|
June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
Yang Wang, Chunyan Xu, Rong Zhang, et al.
Journal of Medicinal Chemistry
|
May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines
Stephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Current Medical Science
|
March 25, 2020
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China
Fang Zheng, Chun Liao, Qi-Hong Fan, et al.
Plos Genetics
|
January 15, 2010
Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis
Yan Guo, Li-Jun Tan, Shu-Feng Lei, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Seminars in Cancer Biology
|
March 10, 2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds
A R M Ruhul Amin, Phillip A Karpowicz, Thomas E Carey, et al.
The Lancet. Digital Health
|
May 1, 2025
Non-invasive biopsy diagnosis of diabetic kidney disease via deep learning applied to retinal images: a population-based study
Ziyao Meng, Zhouyu Guan, Shujie Yu, et al.
Page
of 75
Search research articles
Search
Showing results (731-740 of 743) with videos related to
Sort By:
Page
of 75
Journal of Medicinal Chemistry
|
February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors
Noel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
American Journal of Human Genetics
|
November 11, 2008
Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis
Tie-Lin Yang, Xiang-Ding Chen, Yan Guo, et al.
Cell Metabolism
|
January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth
Siyuan Xia, Ruiting Lin, Lingtao Jin, et al.
The Lancet. Infectious Diseases
|
June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study
Yang Wang, Chunyan Xu, Rong Zhang, et al.
Journal of Medicinal Chemistry
|
May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines
Stephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Current Medical Science
|
March 25, 2020
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China
Fang Zheng, Chun Liao, Qi-Hong Fan, et al.
Plos Genetics
|
January 15, 2010
Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis
Yan Guo, Li-Jun Tan, Shu-Feng Lei, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Seminars in Cancer Biology
|
March 10, 2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds
A R M Ruhul Amin, Phillip A Karpowicz, Thomas E Carey, et al.
The Lancet. Digital Health
|
May 1, 2025
Non-invasive biopsy diagnosis of diabetic kidney disease via deep learning applied to retinal images: a population-based study
Ziyao Meng, Zhouyu Guan, Shujie Yu, et al.
Page
of 75